About
Egle Therapeutics is a biotechnology company developing precision medicines that modulate regulatory T cells to treat autoimmune diseases and cancer, with clinical-stage candidates targeting IL-2 pathways.
Explore Egle Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.